JAN BIOTECH, INC.
ITHACA, NY · Medtech · Private
A rapid RT-qPCR assay for detecting and discriminating SARS-CoV-2 variants, including unknown variants, without requiring sequencing
janbiotech.com →- Grants
- $8.9M
- 16 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $3.0M
- 2 awards · the Interior, Defense
- #171 of 4531 in medtech
- Patents
- 5
- 2 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Real-Time Spliced-RNA Detection to Quantify Latent HIV-Infected Cells in HAART Patients | $242,204 | |
| Federal grant | Department of Health and Human Services · Phase I · Point-of-Care Spliced RNA Diagnostic for Oral Detection of Replication-Competent Latent HIV-1 Infection | $213,238 | |
| Federal grant | Department of Health and Human Services · Phase I · Real-Time Spliced-RNA Detection to Quantify Latent HIV-Infected Cells in HAART Patients | $74,352 | |
| Federal grant | Department of Health and Human Services · Phase I · Real-Time Spliced-RNA Detection to Quantify Latent HIV-Infected Cells in HAART Patients | $40,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Control Kit for Latent HIV Diagnostics | $288,893 | |
| Federal grant | Department of Health and Human Services · Phase II · Real-Time Spliced-RNA Detection to Quantify Latent HIV-Infected Cells in HAART Patients | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Real-Time Spliced-RNA Detection to Quantify Latent HIV-Infected Cells in HAART Patients | $997,824 | |
| Federal contract | Department of the Interior · Assateague Island National Seashore. Wild Ponies Genome Study | $30,923 | |
| Federal grant | Department of Defense · Phase I · Hybrid Nano-Bio-Electronic Odor Detector | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Real-Time Spliced-RNA Detection to Quantify Latent HIV-Infected Cells in HAART Patients | $1,000,000 | |
| Federal grant | Department of Defense · Phase II · Hybrid Nano-Bio-Electronic Odor Detector | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Sequence-based RNA Fluorescence Assay to Measure Latent HIV Reservoirs | $291,256 | |
| Federal grant | Department of Health and Human Services · Phase II · Sequence-based RNA Fluorescence Assay to Measure Latent HIV Reservoirs | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid COVID-19 Mutation Discrimination Test for Global SARS-CoV-2 Variant Surveillance | $275,766 | |
| Federal grant | Department of Health and Human Services · Phase II · Sequence-based RNA Fluorescence Assay to Measure Latent HIV Reservoirs | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Pediatric Latent HIV Reservoir Characterization and Quantification Assay | $300,000 | |
| Federal contract | Department of Defense · Dha SBIR Direct Phase II H2D-0219 Sample Collection And Processing Methods To Support Battlefield Wound Infection Diagnostics | $3,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Sequence-based RNA Fluorescence Assay to Measure Latent HIV Reservoirs | $1,000,000 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 168 | SYNDAVER LABS INC. | $3.0M | $1.0M |
| 169 | ADVANCED CELL DIAGNOSTICS, INC. | $3.0M | — |
| 170 | Cardiovascular Systems | $3.0M | $5.0M |
| 171 | JAN BIOTECH, INC. | $3.0M | — |
| 172 | MALCOVA INC | $3.0M | — |
| 173 | BERTEC CORP | $3.0M | — |
| 174 | Altrazeal LIfe Sciences Inc | $3.0M | $15M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Oligonucleotide-Templated Photoreduction Fluorogenic Probe Pairs and Their Use in Quantitative Detection of Target RNA Sequencesapplication
- Oligonucleotide-Templated Photoreduction Fluorogenic Probe Pairs and Their Use in Quantitative Detection of Target RNA Sequencesgranted
- Fluorogenic Probes And Their Use In Quantitative Detection Of Target Rna Sequencesgranted
- Obligonucleotide-Templated Photoreduction Fluorogenic Probe Pairs and Their Use in Quantitative Detection of Target RNA Sequencesapplication
- Fluorogenic Probes and Their Use in Quantitative Detection of Target RNA Sequencesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.